2021 Gartner Critical Capabilities for Endpoint Protection Platforms (EPP)

CrowdStrike Ranks Highest Across All Use Cases

CrowdStrike is recognized by Gartner with the highest scores across all use cases (Types A-C) within the March 2022 update to the 2021 Gartner Critical Capabilities for Endpoint Protection Platforms report. This methodology provides deeper insight into providers’ product and service offerings by extending the Magic Quadrant analysis. Use this research to further investigate product and service ratings based on key capabilities set to important, differentiating use cases.

The CrowdStrike Falcon®^® endpoint protection platform is built to stop breaches:

• The Falcon platform’s single, lightweight-agent architecture leverages cloud-scale artificial intelligence (AI) and offers real-time protection and visibility across the enterprise, preventing attacks on endpoints on or off the network.
• Powered by the CrowdStrike Security Cloud, the Falcon platform correlates trillions of security events per day in real time from across the globe, fueling one of the world’s most advanced data platforms for security.
• With CrowdStrike, customers benefit from better protection, better performance and immediate time-to-value delivered by the cloud-native Falcon platform.

^{Gartner, Critical Capabilities for Endpoint Protection Platforms, Mark Harris, Peter Firstbrook, Rob Smith, Paul Webber, Prateek Bhajanka, 6 May 2021 and updated 22 March 2022. GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved.}

^{Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.}